These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 7753054)

  • 1. International guide to drugs for Parkinson's disease.
    Oertel WH; Dodel RC
    Mov Disord; 1995 Mar; 10(2):121-31. PubMed ID: 7753054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacotherapy for Parkinson's disease.
    Chen JJ; Swope DM
    Pharmacotherapy; 2007 Dec; 27(12 Pt 2):161S-173S. PubMed ID: 18041936
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future directions in the treatment of Parkinson's disease.
    Schapira AH
    Mov Disord; 2007 Sep; 22 Suppl 17():S385-91. PubMed ID: 18175401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parkinson's disease.
    Imke S
    Adv Nurse Pract; 1998 Jan; 6(1):24-8. PubMed ID: 9495941
    [No Abstract]   [Full Text] [Related]  

  • 5. Parkinson's disease: drug therapy.
    Oertel WH; Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):89-108. PubMed ID: 9426870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group.
    Bhatia K; Brooks DJ; Burn DJ; Clarke CE; Playfer J; Sawle GV; Schapira AH; Stewart D; Williams AC
    Hosp Med; 1998 Jun; 59(6):469-80. PubMed ID: 9775275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in Parkinson's disease therapy: use of monoamine oxidase inhibitors.
    Henchcliffe C; Schumacher HC; Burgut FT
    Expert Rev Neurother; 2005 Nov; 5(6):811-21. PubMed ID: 16274338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying poor symptom control in Parkinson's disease.
    Scott L
    Nurs Times; 2006 Mar 21-27; 102(12):30-2. PubMed ID: 16594560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New drugs in the future treatment of Parkinson's disease.
    Djaldetti R; Melamed E
    J Neurol; 2002 Sep; 249 Suppl 2():II30-5. PubMed ID: 12375061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Initial treatment of Parkinson's disease].
    Kulisevsky J; López-Villegas D
    Rev Neurol; 1997 Aug; 25 Suppl 2():S163-9. PubMed ID: 9280684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current pharmacotherapy of Parkinson's disease].
    Takáts A
    Orv Hetil; 2000 Mar; 141(10):483-8. PubMed ID: 10750400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease.
    Chen JJ; Swope DM; Dashtipour K
    Clin Ther; 2007 Sep; 29(9):1825-49. PubMed ID: 18035186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parkinson's disease. Therapeutic strategies to improve patient function and quality of life.
    Danisi F
    Geriatrics; 2002 Mar; 57(3):46-50; quiz 52. PubMed ID: 11899548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parkinson's disease therapy: treatment of early and late disease.
    Jankovic J
    Chin Med J (Engl); 2001 Mar; 114(3):227-34. PubMed ID: 11780303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relating mode of action to clinical practice: dopaminergic agents in Parkinson's disease.
    Riederer P; Gerlach M; Müller T; Reichmann H
    Parkinsonism Relat Disord; 2007 Dec; 13(8):466-79. PubMed ID: 17919963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinson's disease: making the diagnosis, selecting drug therapies.
    Scharre DW; Mahler ME
    Geriatrics; 1994 Oct; 49(10):14-6, 20-3. PubMed ID: 7926845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selegiline: a second look. Six years later: too risky in Parkinson's disease.
    Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pharmacological targets for the treatment of Parkinson's disease.
    Schapira AH; Bezard E; Brotchie J; Calon F; Collingridge GL; Ferger B; Hengerer B; Hirsch E; Jenner P; Le Novère N; Obeso JA; Schwarzschild MA; Spampinato U; Davidai G
    Nat Rev Drug Discov; 2006 Oct; 5(10):845-54. PubMed ID: 17016425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy in Parkinson's disease].
    van Hilten JJ; Roos RA
    Ned Tijdschr Geneeskd; 1999 Jan; 143(5):234-40. PubMed ID: 10086151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAO-B inhibitors in Parkinson's disease.
    Olanow CW
    Adv Neurol; 1993; 60():666-71. PubMed ID: 8420207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.